We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
Cap. Flow
-$2.97B
Cap. Flow %
-3.9%
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$77.3M
2
BX icon
Blackstone
BX
+$53.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$40.8M
4
PLTR icon
Palantir
PLTR
+$34.3M
5
SNOW icon
Snowflake
SNOW
+$24.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$163M
3
LIN icon
Linde
LIN
+$133M
4
AMZN icon
Amazon
AMZN
+$94.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 14.16%
3 Healthcare 12.95%
4 Consumer Discretionary 12.06%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RICK icon
2476
RCI Hospitality Holdings
RICK
$215M
$608K ﹤0.01%
9,184
-4,909
-35% -$344K
NCMI icon
2477
National CineMedia
NCMI
$378M
$607K ﹤0.01%
11,973
-476
-4% -$22.3K
DOCN icon
2478
DigitalOcean
DOCN
$14.6B
$606K ﹤0.01%
+10,908
New +$471K
MCB icon
2479
Metropolitan Bank Holding Corp
MCB
$1.15B
$606K ﹤0.01%
10,061
-1,106
-10% -$67.3K
INBX
2480
DELISTED
Inhibrx, Inc. Common Stock
INBX
$605K ﹤0.01%
+21,977
New +$458K
EVC icon
2481
Entravision Communication
EVC
$1.1B
$603K ﹤0.01%
90,293
-11,902
-12% -$53.8K
CLAR icon
2482
Clarus
CLAR
$143M
$601K ﹤0.01%
23,371
-12,642
-35% -$270K
IWP icon
2483
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$601K ﹤0.01%
+5,306
New +$567K
PASG icon
2484
Passage Bio
PASG
$14.1M
$601K ﹤0.01%
2,269
+808
+55% +$250K
PAE
2485
DELISTED
PAE Incorporated Class A Common Stock
PAE
$598K ﹤0.01%
67,173
+3,217
+5% +$27.7K
ALTO icon
2486
Alto Ingredients
ALTO
$340M
$597K ﹤0.01%
+97,787
New +$569K
ORIC icon
2487
Oric Pharmaceuticals
ORIC
$1.4B
$597K ﹤0.01%
33,774
+11,287
+50% +$247K
EGIO
2488
DELISTED
Edgio, Inc. Common Stock
EGIO
$597K ﹤0.01%
4,741
+986
+26% +$130K
CARM
2489
DELISTED
Carisma Therapeutics
CARM
$594K ﹤0.01%
+6,427
New +$410K
FREE
2490
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$593K ﹤0.01%
+40,920
New +$546K
LORL
2491
DELISTED
Loral Space and Communications, Inc.
LORL
$592K ﹤0.01%
15,229
-5,994
-28% -$228K
AMK
2492
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$591K ﹤0.01%
23,583
+2,205
+10% +$53.6K
MCF
2493
DELISTED
Contango Oil & Gas Co.
MCF
$590K ﹤0.01%
136,578
+3,196
+2% +$13.4K
BCOV
2494
DELISTED
Brightcove, Inc.
BCOV
$589K ﹤0.01%
41,030
-2,755
-6% -$44.2K
STOK icon
2495
Stoke Therapeutics
STOK
$2.11B
$588K ﹤0.01%
17,470
+1,963
+13% +$69.4K
SWIM icon
2496
Latham Group
SWIM
$880M
$583K ﹤0.01%
+18,229
New +$532K
XPRO icon
2497
Expro Ltd
XPRO
$1.91B
$582K ﹤0.01%
31,990
-4,513
-12% -$93.2K
SFT
2498
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$582K ﹤0.01%
+6,784
New +$543K
HCCI
2499
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$579K ﹤0.01%
19,504
-4,865
-20% -$144K
MVBF icon
2500
MVB Financial
MVBF
$389M
$578K ﹤0.01%
13,549
-1,303
-9% -$53.2K

Similar funds

RhumbLine Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.

  • RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
  • RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
  • RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
  • RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
  • RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
  • RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.